Boehringer Ingelheim’s Ingelvac CircoFLEX reaches two billion uses

Boehringer Ingelheim has announced that its highly successful Ingelvac CircoFLEX vaccine has passed a monumental usage milestone.

More than two billion pigs around the world have now been protected against porcine circovirus (PCV) disease using Ingelvac CircoFLEX to date, underlining its status as the most successful animal health vaccine of all time, based on yearly sales.

It means more than eight pigs are being vaccinated every second worldwide, allowing the product to play a key role in protecting sustainable production and the supply of healthy, nutritious pork.

Ingelvac CircoFLEX is licensed to be freshly mixed with Ingelvac MycoFLEX to protect pigs against both PCV 2 and Mycoplasma hyopneumoniae in a single shot. It was recently approved in Europe for use in sows.

George Heidgerken, head of Boehringer Ingelheim Animal Health, said: "We continue to strive to provide the best protection against porcine circovirus to the global pig industry by an integrated solutions approach. This includes the supply of a high-quality vaccine and tailored customer services."

This comes after the firm recently announced that its Ingelvac PRRS MLV vaccine has been used to immunise one billion pigs against porcine reproductive and respiratory syndrome.

With over 20 years of experience within the animal health market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current animal health roles we have available, you can search for the latest job roles, register your details, or contact the team today.